Related Experiment Video

Updated: Aug 23, 2026

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
10:27

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells

Published on: March 9, 2012

RACK1 regulates G1/S progression by suppressing Src kinase activity

Vidya Mamidipudi1, Jian Zhang, Kelly C Lee

  • 1Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305-5187, USA.

Molecular and Cellular Biology
|July 16, 2004
PubMed

Insights

RACK1 protein inhibits cancer cell growth by controlling the G(1) cell cycle checkpoint. It suppresses Src kinase activity, delaying DNA replication and cell division, revealing a new cancer control mechanism.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Cancer genes often target the G(1) cell cycle checkpoint, allowing uncontrolled cell division.
  • RACK1 (Receptor for Activated C Kinase 1) was previously shown to inhibit Src tyrosine kinase and NIH 3T3 cell growth.
  • RACK1 prolongs the G(0)/G(1) phase, suggesting a role in cell cycle regulation.

Purpose of the Study:

  • To investigate the mechanism by which RACK1 influences the G(1) cell cycle checkpoint.
  • To determine RACK1's role in regulating Src kinase activity and downstream signaling pathways.
  • To elucidate RACK1's function in controlling cell proliferation in the context of cancer.

Main Methods:

  • Overexpression of RACK1 in NIH 3T3 cells.
  • Downregulation of RACK1 using short interference RNA (siRNA).
  • Analysis of cell cycle progression (G(1) arrest, G(1)/S progression).
  • Assessment of key cell cycle regulators (cyclins, CDKs, CDK inhibitors, transcription factors).
  • Investigation of signaling pathways involving Src, Vav2, Rho GTPases, Stat3, and Myc.

Main Results:

  • RACK1 overexpression induces a partial G(1) arrest by suppressing Src activity at the G(1) checkpoint.
  • RACK1 inhibits downstream targets including Vav2, Rho GTPases, Stat3, and Myc via Src.
  • Suppression of cyclin D1, CDK4, and CDK2; activation of p27 and retinoblastoma protein; sequestration of E2F1, leading to delayed G(1)/S progression.
  • RACK1 downregulation activates Src-mediated signaling, accelerating G(1)/S progression.
  • Stat3 is required for Rac1-induced Myc expression.

Conclusions:

  • RACK1 acts as an endogenous inhibitor of Src kinase, providing novel cell cycle control at the late G(1) checkpoint.
  • RACK1's mechanism involves suppressing Src activity, which subsequently inhibits key proteins driving cell cycle progression.
  • This study reveals a new pathway for regulating cell division, with potential implications for cancer therapy targeting the G(1) checkpoint.

More Related Videos

Spatiotemporal Control of Protein Activity through Optogenetic Allosteric Regulation08:00

Spatiotemporal Control of Protein Activity through Optogenetic Allosteric Regulation

Published on: October 4, 2024

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...